Navigation Links
Cohera Medical Awarded Platform Patent on its Biodegradable Adhesive Technology
Date:5/30/2012

PITTSBURGH, May 30, 2012 /PRNewswire/ -- Cohera Medical, Inc.®, a leading innovator and developer of absorbable surgical adhesives and sealants, today announced that the U.S. Patent and Trademark Office (USPTO) has issued the Company patent number 8,182,647, titled "Hydrophilic Biodegradable Adhesives".

The patent relates to a broad platform of novel adhesives including the Company's initial commercial product TissuGlu® Surgical Adhesive, a surgical adhesive used for large flap tissue approximation.  The adhesives covered by the patent are high-strength, completely synthetic and resorbable.  In addition, they have easy application in the operating theatre and are biocompatible for internal human use.  The patent covers variations of adhesives that allow for multiple products with varying strengths and cure properties, thereby enabling the development of products for additional clinical applications. 

"The unique chemistry of these synthetic adhesives is a breakthrough discovery in the field of medical glues," said Eric Beckman, PhD, Chief Scientific Officer of Cohera Medical and the patent's primary inventor.  "The development of this technology has taken many years to perfect, and this patent is the culmination of a significant research effort by the company." 

"We are excited to add this patent to our growing intellectual property portfolio, which solidifies our leadership position in internal surgical adhesives," said Patrick Daly, President and Chief Executive Officer of Cohera Medical. "This patent protects the core of our proprietary technology as well as the key features of our products that make them commercially and clinically viable."

Cohera Medical recently received CE Marking approval for its lead product TissuGlu  and began selling product to hospitals and surgeons in Germany in 2011. TissuGlu has been used successfully in over 350 surgical procedures in Germany by leading plastic and reconstructive surgeons. The product is currently undergoing clinical trials in the U.S.

About Cohera Medical

Cohera Medical, Inc.® is a leading innovator and developer of absorbable surgical adhesives and sealants. The Company's first product, TissuGlu® Surgical Adhesive, is an internal surgical adhesive for large flap surgeries, such as abdominoplasty (tummy tuck), that help eliminate or reduce fluid accumulation and the need for post surgical drains.  TissuGlu's chemical composition is resorbable, non-toxic, forms a strong bond between tissue layers and allows for natural healing, which ultimately may enable faster recovery. TissuGlu has received CE Marking approval to be sold in the European Union (EU).  Cohera Medical is also developing a unique and proprietary bowel sealant, and a strong adhesive for mesh fixation. Outside of the EU, TissuGlu and the other Cohera products are currently indicated for investigational use only and have not yet been approved for marketing by the Food and Drug Administration (FDA) in the U.S. or in any other market.  For more information, visit www.coheramed.com.

Certain statements made throughout this press release that are not historical facts contain forward-looking statements regarding the Company's future plans, objectives and expected performance. Any such forward-looking statements are based on assumptions that the Company believes are reasonable, but are subject to a wide range of risks and uncertainties and, therefore, there can be no assurance that actual results may not differ materially from those expressed or implied by such forward-looking statements.

 


'/>"/>
SOURCE Cohera Medical, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Scotland opens stem cell research center and bio-medical incubator
2. Bunker Hill Community College Holds Biomedical Careers Graduation Ceremony
3. Paratek Announces Appointments of Dennis Molnar as Chief Executive Officer and Director and of Dr. Evan Loh as Chief Medical Officer and Chairman of the Board of Directors
4. Fluke Biomedical training center goes global: adds multi-language support
5. MD+DI, the Global MedTech Industry Authority, Wins a 2012 Maggie for Best Overall Category in Medical, Dental & Related Services/Trade
6. MD+DI, the Global MedTech Industry Authority, Wins a 2012 Maggie for Best Cover in the Medical, Dental & Related Services/Trade Category
7. Customer Satisfaction, A key to Success: Narang Medical Limited
8. MD&M East 2012 to Feature FDA and Medical Technology Development Leaders
9. UBM Canon, the Global MedTech Authority, and the Medical Design Excellence Awards Announce Dean Kamen as the Presenter of the 2012 Lifetime Achievement Award
10. Ikaria® Appoints Chief Medical Officer
11. Nation Must Invest in Biomedical Research/Health Workforce, AAHC President Tells Congress
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... ... February 22, 2017 , ... ... addition of Tom Perkins as European director. Operating from Pennside’s Zurich headquarters, Pennside ... , Perkins joins Pennside after more than a decade with leading market ...
(Date:2/22/2017)... N.C., Feb. 22, 2017  United Therapeutics Corporation (NASDAQ: ... results for the fourth quarter and year ended ... results reflect continued growth as net revenues reached ... Martine Rothblatt, Ph.D., United Therapeutics, Chairman and Chief ... to develop and advance our growing product pipeline, ...
(Date:2/21/2017)... Feb. 21, 2017 /PRNewswire/ - SQI Diagnostics Inc. ("SQI" or the ... results for the three months ended December 31, 2016. ... life sciences and diagnostics company that develops and commercializes proprietary ... ... build on the commercial milestones achieved in fiscal 2016," said ...
(Date:2/21/2017)... ... February 21, 2017 , ... ... Liquid Biopsy System , a fully automated benchtop system for collecting intact circulating ... is being launched at the Molecular Medicine Tri Conference (Tri-Con) Annual Meeting 2017 ...
Breaking Biology Technology:
(Date:2/1/2017)... BOSTON, Massachusetts , February 1, 2017 ... and events on emerging technology, announces the availability of a new ... Continue Reading ... ... systems in industrial and collaborative robots. Source: IDTechEx Report "Sensors for ...
(Date:1/30/2017)... --  Invitae Corporation (NYSE: NVTA ), ... announced that it will report its fourth quarter and ... Monday, February 13, 2017, and Invitae,s management team will ... Eastern / 1:45 p.m. Pacific. During ... results, guidance, and recent developments and will spend the ...
(Date:1/26/2017)... DENVER , Jan. 26, 2017  Acuity ... Trends for Biometrics and Digital Identity".  Acuity characterizes ... digital identity when increased adoption reflects a new ... "Biometrics and digital identity are ... says Maxine Most , Principal of Acuity ...
Breaking Biology News(10 mins):